0% found this document useful (0 votes)
17 views

RNA Helicase DDX5 Maintains Cardiac Function by Regulating Alternative Splicing

Uploaded by

Eve Bedin
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
17 views

RNA Helicase DDX5 Maintains Cardiac Function by Regulating Alternative Splicing

Uploaded by

Eve Bedin
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

ADVERTISEMENT

BECOME A MEMBER | VOLUNTEER | DONATE

AHAIASAJournals JOURNALS | BROWSE | RESOURCES | INFORMATION | ALERTS SIGN IN REGISTER

CURRENT ISSUE | ARCHIVE | JOURNAL INFORMATION | FEATURES SUBMIT

RESEARCH ARTICLE Originally Published 26 July 2024

RNA Helicase DDX5 Maintains Cardiac


Function by Regulating CamkIIδ Alternative
Splicing
Kangni Jia, MD, PhD  , Haomai Cheng, MD  , Wenqi Ma, MD, PhD  , Lingfang Zhuang, MD, PhD, Hao Li, MD  , Zhigang Li,

PhD, Ziyang Wang, MD, … SHOW ALL …, and Xiaoxiang Yan, MD, PhD   AUTHOR INFO & AFFILIATIONS

Circulation New online https://doi.org/10.1161/CIRCULATIONAHA.123.064774

   PDF/EPUB

Abstract
ADVERTISEMENT
 BACKGROUND: 

Heart failure (HF) is a leading cause of morbidity and mortality worldwide. RNA- 
binding proteins are identified as regulators of cardiac disease; DDX5 (dead-box

helicase 5) is a master regulator of many RNA processes, although its function in
heart physiology remains unclear. 

METHODS: 

We assessed DDX5 expression in human failing hearts and a mouse HF model. 


To study the function of DDX5 in heart, we engineered cardiomyocyte-specific 
Ddx5 knockout mice. We overexpressed DDX5 in cardiomyocytes using adeno-
associated virus serotype 9 and performed transverse aortic constriction to ADVERTISEMENT

establish the murine HF model. The mechanisms underlined were subsequently


investigated using immunoprecipitation–mass spectrometry, RNA-sequencing,
alternative splicing analysis, and RNA immunoprecipitation sequencing.

RESULTS:

We screened transcriptome databases of murine HF and human dilated


cardiomyopathy samples and found that DDX5 was significantly downregulated
in both. Cardiomyocyte-specific deletion of Ddx5 resulted in HF with reduced
cardiac function, an enlarged heart chamber, and increased fibrosis in mice.
DDX5 overexpression improved cardiac function and protected against adverse
cardiac remodeling in mice with transverse aortic constriction–induced HF.
Furthermore, proteomics revealed that DDX5 is involved in RNA splicing in
cardiomyocytes. We found that DDX5 regulated the aberrant splicing of
Ca2+/calmodulin-dependent protein kinase IIδ (CamkIIδ), thus preventing the
production of CaMKIIδA, which phosphorylates L-type calcium channel by serine
residues of Cacna1c, leading to impaired Ca2+ homeostasis. In line with this, we
found increased intracellular Ca2+ transients and increased sarcoplasmic
reticulum Ca2+ content in DDX5-depleted cardiomyocytes. Using adeno-
associated virus serotype 9 knockdown of CaMKIIδA partially rescued the
cardiac dysfunction and HF in Ddx5 knockout mice.

CONCLUSIONS:

These findings reveal a role for DDX5 in maintaining calcium homeostasis and
cardiac function by regulating alternative splicing in cardiomyocytes, identifying
the DDX5 as a potential target for therapeutic intervention in HF.

Formats available
You can view the full content in the following formats:

VIEW PDF/EPUB

Supplemental Material
File (circ_circulationaha-2023-064774_supp1.pdf)

DOWNLOAD 21.16 MB

File (circ_circulationaha-2023-064774_supp2.pdf)

DOWNLOAD 36.39 MB

eLetters
eLetters should relate to an article recently published in the journal and are not a
forum for providing unpublished data. Comments are reviewed for appropriate use
of tone and language. Comments are not peer-reviewed. Acceptable comments are
posted to the journal website only. Comments are not published in an issue and are
not indexed in PubMed. Comments should be no longer than 500 words and will only
be posted online. References are limited to 10. Authors of the article cited in the
comment will be invited to reply, as appropriate.

Comments and feedback on AHA/ASA Scientific Statements and Guidelines should


be directed to the AHA/ASA Manuscript Oversight Committee via its
Correspondence page.

SIGN IN TO SUBMIT A RESPONSE TO THIS ARTICLE

Download PDF

BROWSE RESOURCES INFORMATION


Circulation
Collections CME For Authors

Subject Terms DEIA Resources For Reviewers

AHA Journal Podcasts Early Career Resources For Subscribers


SUBMIT
Trend Watch AHA Journals @ Meetings For International Users

Arteriosclerosis, Thrombosis, and Vascular Biology Journal of the American Heart Association Circulation: Genomic and Precision Medicine

Circulation Circulation: Arrhythmia and Electrophysiology Circulation: Heart Failure

Circulation Research Circulation: Cardiovascular Imaging Stroke: Vascular and Interventional Neurology

Hypertension Circulation: Cardiovascular Interventions Annals of Internal Medicine: Clinical Cases

Stroke Circulation: Cardiovascular Quality & Outcomes

ABOUT US GET INVOLVED OUR SITES

About the AHA/ASA Donate American Heart Association

Annual report Advocate American Stroke Association

AHA Financial Information Volunteer CPR & ECC

Careers ShopHeart Go Red For Women

International Programs ShopCPR More Sites

Latest Heart and Stroke News

National Center AHA/ASA Media Newsroom


7272 Greenville Ave.Dallas, TX 75231

Customer Service
1-800-AHA-USA-1
1-800-242-8721

Hours
Monday - Friday: 7 a.m. – 7 p.m. CT
Saturday: 9 a.m. - 5 p.m. CT
Closed on Sundays

Tax Identification Number


13-5613797

AHA Careers | Privacy Policy | Medical Advice Disclaimer | Copyright Policy | Accessibility Statement | Ethics Policy |
Conflict of Interes Policy | Linking Policy | Whistleblower Policy | Content Editorial Guidelines | Diversity | Suppliers & Providers |
State Fundraising Notices

©2023 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.
The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress ™ DHHS, Go Red ™ AHA ; National Wear Red Day® is a registered trademark.

You might also like